| Response to radiotherapy |
| Complete response |
12(48%) |
| Partial response |
10(40%) |
| Stable disease |
03(12%) |
| Disease status on last follow up |
| No evidence of disease |
12(48%) |
| Local recurrence |
08(32%) |
| Metastatic disease |
04(16%) |
| Lost to follow up |
04(16%) |
| Survival |
| Median follow up |
32-months (range 7-76months) |
| Median Survival |
51 months |
| 24months survival |
72% |
|
